You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
迪瑞医疗(300396.SZ):肿瘤标志物质控品Ⅰ获得医疗器械注册证
格隆汇 03-12 16:52

格隆汇 3 月 12日丨迪瑞医疗(300396.SZ)公布,公司于近日取得由国家药品监督管理局颁发的1项《医疗器械注册证》,产品名称为肿瘤标志物质控品Ⅰ。

化学发光免疫分析是体外诊断行业最重要的细分项目之一,公司布局化学发光免疫产业多年,目前进入到收获期,销售渠道布局正在逐步完善当中。公司发光产品可以进行甲状腺功能、传染病、性激素、骨代谢、炎症、肿瘤标志物、糖代谢、心肌标志物、肾功能、高血压、肝纤维化、贫血等项目的检测。目前,公司化学发光免疫分析仪器相关产品有CM-180、CM-320、CM-320i全自动化学发光免疫分析仪及CSM-8000模块化生化免疫分析系统,化学发光免疫分析试剂相关产品注册证拥有约90项,是国内体外诊断行业化学发光检测项目较为齐全的厂家之一。在未来发展中,公司将继续开发补充临床高价值检验项目,持续丰富体外诊断产品覆盖领域,助力公司快速发展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account